Search for: "N V Organon" Results 1 - 8 of 8
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape… [read post]
26 Aug 2009, 6:12 am
The Corporate Gold Rush to Patent Your Genes’ perpetuates popular misperceptions surrounding gene patents (Holman's Biotech IP Blog) Australian pharmaceutical patent term extension for patches and implants: N V Organon; LTS Lohmann Therapie-Systeme AG and Schwarz Pharma Limited (Patent Baristas) China: Obama Administration and compulsory licensing in China (China Hearsay) China: Forty-two of Simcere’s generic drugs enter China’s Essential… [read post]
20 Nov 2014, 1:22 am by Jani
Organon, where the US Trademark Trial and Appeal Board saw that "[flavoring] performs a utilitarian function that cannot be monopolized without hindering competition". [read post]
27 Jul 2012, 12:40 pm by Bexis
Intron/Temodar Consumer Class Action, 2010 WL 2346624, at *8 n.6 (D.N.J. [read post]
1 Oct 2009, 2:14 am
Organon USA, Inc., 2007 WL 4365312 (D.N.J. [read post]
1 Mar 2007, 4:57 am by Ricky E. Bagolie
The third generation oral contraceptives containing desogestrel are:Desogestrel and Ethinyl Estradiol (Duramed/Barr and Watson Pharmaceuticals)Desogen (Organon)Mircette (Duramed/Barr)Velivet (Duramed)Apri-28 (Duramed/Barr)Kariva (Duramed/Barr)Ortho-Cept (Ortho-McNeil)Reclipsen (Watson)Cyclessa (Organon)It is estimated that women in the U.S. filled more than 7.5 million prescriptions for third generation oral contraceptives this past year (November 2005 to October 2006) (IMS,… [read post]